Ovarian carcinoma cell survival pathways

Ovarian carcinoma cell survival pathways represent the collective molecular mechanisms that allow ovarian cancer cells to persist and thrive. Research has identified multiple distinct molecular pathways activated across different ovarian cancer subtypes. In clear cell ovarian carcinoma, two major pathway clusters have been identified: one dominated by ARID1A mutations with enriched metabolic pathway expression and platinum resistance markers, and another characterized by TP53 mutations with activated extracellular matrix organization and mesenchymal differentiation pathways[1]. In high-grade serous carcinoma, key survival pathways include the PI3K/AKT signaling cascade (frequently activated by PIK3CA mutations in 49% of clear cell cases), inositol phosphate metabolism, cell cycle regulation (particularly elevated in the C1 subtype), RTK-RAS signaling, WNT pathway activation, and angiogenesis pathways[1][2]. The Stem-A subtype shows elevated microtubule activity essential for cell survival[3]. Rather than a single target, these pathways represent a complex interplay of genomic alterations, transcriptional programs, and metabolic adaptations that collectively determine tumor behavior and treatment response.